These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15983230)

  • 41. Leptin receptor gene variation predicts weight change in subjects with impaired glucose tolerance.
    Zacharova J; Chiasson JL; Laakso M
    Obes Res; 2005 Mar; 13(3):501-6. PubMed ID: 15833934
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Single-nucleotide polymorphism rs7754840 of CDKAL1 is associated with impaired insulin secretion in nondiabetic offspring of type 2 diabetic subjects and in a large sample of men with normal glucose tolerance.
    Stancáková A; Pihlajamäki J; Kuusisto J; Stefan N; Fritsche A; Häring H; Andreozzi F; Succurro E; Sesti G; Boesgaard TW; Hansen T; Pedersen O; Jansson PA; Hammarstedt A; Smith U; Laakso M;
    J Clin Endocrinol Metab; 2008 May; 93(5):1924-30. PubMed ID: 18285412
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Leu7Pro polymorphism in the neuropeptide Y (NPY) gene is associated with impaired glucose tolerance and type 2 diabetes in Swedish men.
    Nordman S; Ding B; Ostenson CG; Kärvestedt L; Brismar K; Efendic S; Gu HF
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):282-7. PubMed ID: 15926114
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.
    Viswanathan V; Clementina M; Nair BM; Satyavani K
    J Assoc Physicians India; 2007 Dec; 55():833-7. PubMed ID: 18405128
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The influence of genetic variations in HHEX gene on insulin metabolism in the German MESYBEPO cohort.
    Pivovarova O; Nikiforova VJ; Pfeiffer AF; Rudovich N
    Diabetes Metab Res Rev; 2009 Feb; 25(2):156-62. PubMed ID: 19117022
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Study of genetic prediabetic south Indian subjects. Importance of hyperinsulinemia and beta-cell dysfunction.
    Snehalatha C; Ramachandran A; Satyavani K; Latha E; Viswanathan V
    Diabetes Care; 1998 Jan; 21(1):76-9. PubMed ID: 9538973
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Resveratrol Improves Glycemic Control in Type 2 Diabetic Obese Mice by Regulating Glucose Transporter Expression in Skeletal Muscle and Liver.
    Yonamine CY; Pinheiro-Machado E; Michalani ML; Alves-Wagner AB; Esteves JV; Freitas HS; Machado UF
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28708105
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term repeatability of measures of early insulin secretion derived from an intravenous glucose tolerance test and conversion from impaired glucose tolerance to diabetes.
    Laaksonen DE; Niskanen L; Mykkänen H; Juntunen KS; Schwab U; Kolehmainen M; Rauramaa R; Tuomilehto J; Uusitupa M
    Ann Med; 2008; 40(4):303-11. PubMed ID: 18428023
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of three glucose transporter genes in a Caucasian population: no associations with non-insulin-dependent diabetes and obesity.
    Oelbaum RS
    Clin Genet; 1992 Nov; 42(5):260-6. PubMed ID: 1362530
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program.
    Florez JC; Jablonski KA; Bayley N; Pollin TI; de Bakker PI; Shuldiner AR; Knowler WC; Nathan DM; Altshuler D;
    N Engl J Med; 2006 Jul; 355(3):241-50. PubMed ID: 16855264
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Progression to impaired glucose metabolism in first-degree relatives of patients with type 2 diabetes in Isfahan, Iran.
    Janghorbani M; Amini M
    Diabetes Metab Res Rev; 2009 Nov; 25(8):748-55. PubMed ID: 19862775
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes.
    Nielsen EM; Hansen L; Carstensen B; Echwald SM; Drivsholm T; Glümer C; Thorsteinsson B; Borch-Johnsen K; Hansen T; Pedersen O
    Diabetes; 2003 Feb; 52(2):573-7. PubMed ID: 12540638
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical risk factors, DNA variants, and the development of type 2 diabetes.
    Lyssenko V; Jonsson A; Almgren P; Pulizzi N; Isomaa B; Tuomi T; Berglund G; Altshuler D; Nilsson P; Groop L
    N Engl J Med; 2008 Nov; 359(21):2220-32. PubMed ID: 19020324
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of the clusterin gene polymorphisms with type 2 diabetes mellitus.
    Daimon M; Oizumi T; Karasawa S; Kaino W; Takase K; Tada K; Jimbu Y; Wada K; Kameda W; Susa S; Muramatsu M; Kubota I; Kawata S; Kato T
    Metabolism; 2011 Jun; 60(6):815-22. PubMed ID: 20850846
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Receptor for advanced glycation end product polymorphisms and type 2 diabetes: the CODAM study.
    Gaens KH; van Der Kallen CJ; van Greevenbroek MM; Feskens EJ; Stehouwer CD; Schalkwijk CG
    Ann N Y Acad Sci; 2008 Apr; 1126():162-5. PubMed ID: 18079485
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The G-250A substitution in the promoter region of the hepatic lipase gene is associated with the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
    Zacharova J; Todorova BR; Chiasson JL; Laakso M;
    J Intern Med; 2005 Feb; 257(2):185-93. PubMed ID: 15656877
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Screening of 134 single nucleotide polymorphisms (SNPs) previously associated with type 2 diabetes replicates association with 12 SNPs in nine genes.
    Willer CJ; Bonnycastle LL; Conneely KN; Duren WL; Jackson AU; Scott LJ; Narisu N; Chines PS; Skol A; Stringham HM; Petrie J; Erdos MR; Swift AJ; Enloe ST; Sprau AG; Smith E; Tong M; Doheny KF; Pugh EW; Watanabe RM; Buchanan TA; Valle TT; Bergman RN; Tuomilehto J; Mohlke KL; Collins FS; Boehnke M
    Diabetes; 2007 Jan; 56(1):256-64. PubMed ID: 17192490
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Changes in glucose metabolism in people with different glucose metabolism disorders at baseline: follow-up results of a Finnish national diabetes prevention programme.
    Rautio N; Jokelainen J; Oksa H; Saaristo T; Peltonen M; Puolijoki H; Tuomilehto J; Vanhala M; Moilanen L; Uusitupa M; Keinänen-Kiukaanniemi S
    Diabet Med; 2015 Dec; 32(12):1611-6. PubMed ID: 25864699
    [TBL] [Abstract][Full Text] [Related]  

  • 59. beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations.
    Pearson ER; Velho G; Clark P; Stride A; Shepherd M; Frayling TM; Bulman MP; Ellard S; Froguel P; Hattersley AT
    Diabetes; 2001 Feb; 50 Suppl 1():S101-7. PubMed ID: 11272165
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes. A longitudinal interventional study.
    Long SD; O'Brien K; MacDonald KG; Leggett-Frazier N; Swanson MS; Pories WJ; Caro JF
    Diabetes Care; 1994 May; 17(5):372-5. PubMed ID: 8062602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.